NCT01427868View on ClinicalTrials.gov

Bioequivalence of LB80380 Free Base and Maleate Salt Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2010

Conditions

Hepatitis B

Interventions

DRUG

LB80380 maleate salt

183 mg (150 mg as a free base)

DRUG

LB80380 free base

150 mg

Trial Locations (1)

Unknown

Clinical Trial Center, Samsung Medical Center, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY

NCT01427868 - Bioequivalence of LB80380 Free Base and Maleate Salt Tablets | Biotech Hunter | Biotech Hunter